Calcific Aortic Valve Stenosis with Aging and Current Development in its Pathophysiology

被引:3
作者
Kodra, Arber [1 ]
Kim, Michael [1 ]
机构
[1] Northwell Hlth Lenox Hill Hosp, Dept Cardiol, New York, NY USA
关键词
advanced glycosylation end product; aortic valve disease; atherosclerosis; biomarkers; valvular heart disease; cardiovascular risk factors; ASSOCIATION; PROGRESSION; MECHANISMS; DISEASE; FETUIN; RISK;
D O I
10.1055/s-0042-1758382
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Aortic stenosis is the most common valvular heart disease affecting the elderly. While most patients have a prolonged asymptomatic phase, the development of symptoms ushers in a phase clinical deterioration that often leads to sudden death without an intervention. Treatment of aortic stenosis with valve replacement often relieves the symptoms but still leaves behind a remodeled left ventricle which may not recover. Understanding the pathophysiology of aortic stenosis and realizing that the disease process may be a more active biological entity rather than a passive degenerative process will help us prevent it. This review serves to summarize the latest literature on the pathophysiology of aortic stenosis in the elderly.
引用
收藏
页码:229 / 231
页数:3
相关论文
共 31 条
  • [31] The effect of statins on valve function and calcification in aortic stenosis: A meta-analysis
    Zhao, Ying
    Nicoll, Rachel
    He, Yi Hua
    Henein, Michael Y.
    [J]. ATHEROSCLEROSIS, 2016, 246 : 318 - 324